Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year.
Chrome Holding Co does not have enough data to calculate 10-Year ROIIC %.
Chrome Holding Co (OTCPK:MEHCQ) 10-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Chrome Holding Co 10-Year ROIIC % Related Terms
Chrome Holding Co 10-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Chrome Holding Co's 10-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEHCQ vs BDSX, XGN, FONR: 10-Year ROIIC % Comparison
For the Diagnostics & Research subindustry, Chrome Holding Co's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chrome Holding Co 10-Year ROIIC % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Chrome Holding Co's 10-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Chrome Holding Co's 10-Year ROIIC % falls into.
Chrome Holding Co's 10-Year ROIIC % for the quarter that ended in Mar. 2025 is calculated as:
10-Year ROIIC %
=
10-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
10-Year Incremental Invested Capital**
=
( -179.1671594 (Mar. 2025) - (Mar. 2015) )
/
( 123.477 (Mar. 2025) - (Mar. 2015) )
=
/
=
N/A%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Chrome Holding Co (MEHCQ) has a 10-Year ROIIC % of 0.00 as of Mar. 2025. 10-Year ROIIC % measures the change in earnings as a percentage of change in investment over 10-year. View historical data on Chrome Holding Co and its competitors.
Is Chrome Holding Co's 10-Year ROIIC % too high?
Chrome Holding Co's current 10-Year ROIIC % is 0.00. Overall, Chrome Holding Co has a GF Score™ of 58/100, reflecting its overall financial health beyond just this single metric.
How does Chrome Holding Co's 10-Year ROIIC % compare to BDSX and XGN?
Chrome Holding Co's 10-Year ROIIC % of 0.00 can be compared against companies in the Medical Diagnostics & Research industry. The industry median 10-Year ROIIC % is 1.28. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year ROIIC % for a Medical Diagnostics & Research company?
The median 10-Year ROIIC % among Medical Diagnostics & Research companies is 1.28, based on 176 companies in the industry. Companies in the top quartile (top 25%) have a 10-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 10-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year ROIIC % mean?
A high 10-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 10-Year ROIIC % measures the change in earnings as a percentage of change in investment over 10-year. View historical data on Chrome Holding Co and its competitors. For the Medical Diagnostics & Research industry, the median 10-Year ROIIC % is 1.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chrome Holding Co's current 10-Year ROIIC % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chrome Holding Co stock overvalued right now?
Chrome Holding Co (MEHCQ) has a current 10-Year ROIIC % of 0.00. The current 10-Year ROIIC % is 0.00. Chrome Holding Co's overall GF Score™ is 58/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year ROIIC % calculated?
10-Year ROIIC % is calculated from a company's financial statements. For Chrome Holding Co (MEHCQ), the current 10-Year ROIIC % is 0.00 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Chrome Holding Co, formerly known as 23andMe Holding Co, is a consumer-facing healthcare technology company, involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes one main sector that is Consumer and Research Services. The company generates maximum revenue from the Consumer and Research Services segment.
58GF Score
Get the complete analysis for MEHCQ
10-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEHCQ has been successfully added to your 
